AMRN Stock: Amarin Corporation plc Stock Price, Analysis & Insights

Get live AMRN stock price $14.89, comprehensive Amarin Corporation plc stock analysis, charts, news, and expert forecast. Real-time AMRN stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

14.89

4.86%Today

AMRN • Amarin Corporation plc • NASDAQ Global Market • Healthcare

Market Cap

307.97M

Volume

180.73K

52W High

20.90

52W Low

12.30

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, German...

Contact Information

Website: https://www.amarincorp.com
Address: Grand Canal Docklands
Country: IE

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Amarin Corporation plc shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Amarin Corporation plc
⚠Investors should consider how Amarin Corporation plc fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

307.97M

P/E Ratio (TTM)

-9.31

Beta

0.82

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare AMRN with peer companies:

AC Immune S.A. (ACIU)

Price: $2.26
Market cap: 230.01M

Altimmune, Inc. (ALT)

Price: $2.66
Market cap: 234.76M

Alto Neuroscience, Inc. (ANRO)

Price: $21.15
Market cap: 742.24M

Cellectis S.A. (CLLS)

Price: $2.99
Market cap: 300.25M

DBV Technologies S.A. (DBVT)

Price: $16.03
Market cap: 383.47M

enGene Holdings Inc. (ENGN)

Price: $1.67
Market cap: 85.50M

Korro Bio, Inc. (KRRO)

Price: $10.94
Market cap: 108.89M

Larimar Therapeutics, Inc. (LRMR)

Price: $3.50
Market cap: 299.52M

Lyell Immunopharma, Inc. (LYEL)

Price: $12.70
Market cap: 296.34M

Silence Therapeutics plc (SLN)

Price: $6.01
Market cap: 283.88M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.